Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.39 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | PDE2A | O00408 | 2/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.37 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.37 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.36 |
| ▸ | PDE6D | O43924 | 1/20 | 0.36 |
| ▸ | PDE6A | P16499 | 1/20 | 0.36 |
| ▸ | PDE6G | P18545 | 1/20 | 0.36 |
| ▸ | PDE6B | P35913 | 1/20 | 0.36 |
| ▸ | PDE6C | P51160 | 1/20 | 0.36 |
| ▸ | PDE6H | Q13956 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29520229 | 1.00 | HSD11B1 (0.47) | HSD11B1MAPTMAPK14PTPN11SCN10A | |
| SCHEMBL20698175 | 0.85 | HSD11B1 (0.49) | HSD11B1PTPN11P2RX7PDE2APDE10A | |
| SCHEMBL1725607 | 0.85 | MAPT (0.49) | MAPTMAPK14ALKKMT2ADPP4 | |
| SCHEMBL20698256 | 0.85 | MAPT (0.49) | HSD11B1MAPTPDE2AKMT2ACYP3A4 | |
| SCHEMBL171101 | 0.82 | HSD11B1 (0.47) | HSD11B1MAPK14PTPN11SCN10AP2RX7 | |
| SCHEMBL17514923 | 0.82 | HSD11B1 (0.47) | HSD11B1PTPN11SCN10AP2RX7PDE2A | |
| SCHEMBL30415275 | 0.82 | MAPT (0.46) | HSD11B1MAPTMAPK14ALKKMT2A | |
| SCHEMBL20698132 | 0.82 | HPGD (0.50) | HSD11B1PTPN11SCN10AP2RX7PDE2A | |
| SCHEMBL20698133 | 0.82 | POLB (0.52) | HSD11B1MAPTMAPK14SCN10AP2RX7 | |
| SCHEMBL20698134 | 0.82 | HSD11B1 (0.41) | HSD11B1MAPTMAPK14PTPN11SCN10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4167740-A1 | ACTIVE COMPOUND COMBINATIONS | Bayer Aktiengesellschaft (DE) | 2023-04-26 | — | — | EP | claimed |
| US-12398107-B2 | Fungicidal nitroanilino substituted pyrazoles | FMC CORPORATION (US) | 2025-08-26 | — | — | US | disclosed |
| EP-4388876-A2 | FUNGICIDAL NITROANILINO SUBSTITUTED PYRAZOLES | FMC Corporation (US) | 2024-06-26 | — | — | EP | disclosed |
| CN-112969688-B | Fungicidal nitroaniline-substituted pyrazoles | FMC公司 | 2024-06-04 | — | — | CN | disclosed |
| EP-3847160-B1 | FUNGICIDAL NITROANILINO SUBSTITUTED PYRAZOLES | FMC CORP (US) | 2024-05-08 | — | — | EP | disclosed |
| EP-3590340-B1 | INTERMEDIATES FOR THE SYNTHESIS OF FUNGICIDAL PYRAZOLES | FMC CORP (US) | 2023-11-15 | — | — | EP | disclosed |
| US-20230148599-A1 | FUNGICIDAL MIXTURES CONTAINING PYRAZOLE DERIVATIVES | FMC CORPORATION | 2023-05-18 | — | — | US | disclosed |
| CN-115989255-A | Aqueous capsule suspension concentrate containing biodegradable ester groups | 拜耳公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-111989328-B | Heterocyclic derivatives as pest control agents | 拜耳公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115955916-A | Active compound combinations | 拜耳公司 | 2023-04-11 | — | — | CN | disclosed |
| WO-2012031061-A2 | FUNGICIDAL PYRAZOLES AND THEIR MIXTURES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-08 | — | — | WO | disclosed |
| WO-2012024586-A1 | FUNGICIDAL PYRAZOLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-23 | — | — | WO | disclosed |
| WO-2012023143-A1 | FUNGICIDAL PYRAZOLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-23 | — | — | WO | disclosed |
| EP-2403834-A1 | Fungicidal pyrazoles | E. I. du Pont de Nemours and Company (US) | 2012-01-11 | — | — | EP | disclosed |
| US-20110319430-A1 | FUNGICIDAL PYRAZOLES | E.I. DU PONT NEMOURS AND COMPANY (US) | 2011-12-29 | — | — | US | disclosed |
| US-20110045101-A1 | FUNGICIDAL SUBSTITUTED AZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-02-24 | — | — | US | disclosed |
| EP-2274284-A2 | FUNGICIDAL SUBSTITUTED AZOLES | E. I. Du Pont de Nemours and Company (US) | 2011-01-19 | — | — | EP | disclosed |
| WO-2010101973-A1 | FUNGICIDAL PYRAZOLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-09-10 | — | — | WO | disclosed |
| WO-2009137538-A2 | FUNGICIDAL SUBSTITUTED AZOLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-11-12 | — | — | WO | disclosed |
| WO-2009137651-A2 | FUNGICIDAL SUBSTITUTED AZOLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319430-A1 | FUNGICIDAL PYRAZOLES | CBR3, CBR1, CYP2S1 | HSD11B1 962/4885MAPT 4737/4885MAPK14 2009/4885 |
| US-20230148599-A1 | FUNGICIDAL MIXTURES CONTAINING PYRAZOLE DERIVATIVES | CYP1B1, CYP4B1, TH | HSD11B1 958/4885MAPT 134/4885MAPK14 1197/4885 |
| US-12398107-B2 | Fungicidal nitroanilino substituted pyrazoles | TH, NOX1, NOX3 | HSD11B1 1144/4885MAPT 216/4885MAPK14 2148/4885 |
| US-20110045101-A1 | FUNGICIDAL SUBSTITUTED AZOLES | CBR3, NOX3, CBR1 | HSD11B1 1193/4885MAPT 4335/4885MAPK14 2980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.